We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$398M
AUM Growth
+$31.2M
Cap. Flow
-$2.81M
Cap. Flow %
-0.71%
Top 10 Hldgs %
41.18%
Holding
60
New
3
Increased
16
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$6.82M
2
ULTA icon
Ulta Beauty
ULTA
+$2.81M
3
HSIC icon
Henry Schein
HSIC
+$2.4M
4
MDT icon
Medtronic
MDT
+$1.58M
5
NVS icon
Novartis
NVS
+$1.46M

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$7.24M
2
FISV
Fiserv Inc
FISV
+$3.18M
3
ZBRA icon
Zebra Technologies
ZBRA
+$2.71M
4
TFC icon
Truist Financial
TFC
+$1.75M
5
GNTX icon
Gentex
GNTX
+$1.66M

Sector Composition

Rank Sector Weight
1 Technology 25.23%
2 Healthcare 19.2%
3 Consumer Staples 14.04%
4 Financials 13.81%
5 Consumer Discretionary 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.82M 1.46%
16,323
KO icon
27
Coca-Cola
KO
$377B
$5.52M 1.39%
93,720
GNTX icon
28
Gentex
GNTX
$4.97B
$5.49M 1.38%
168,203
-53,803
-24% -$1.66M
HSIC icon
29
Henry Schein
HSIC
$9.77B
$5.47M 1.37%
72,232
+34,244
+90% +$2.4M
SEIC icon
30
SEI Investments
SEIC
$12.4B
$5.37M 1.35%
84,430
-59
-0.1% -$3.44K
LHX icon
31
L3Harris
LHX
$51.6B
$5.31M 1.33%
25,216
+424
+2% +$79.6K
TFC icon
32
Truist Financial
TFC
$63.3B
$5.11M 1.28%
138,428
-55,838
-29% -$1.75M
OTIS icon
33
Otis Worldwide
OTIS
$27.4B
$5.08M 1.28%
56,762
+939
+2% +$78.1K
WTW icon
34
Willis Towers Watson
WTW
$31.2B
$5.06M 1.27%
20,970
AON icon
35
Aon
AON
$76.5B
$4.51M 1.13%
15,505
-1,166
-7% -$373K
PEP icon
36
PepsiCo
PEP
$190B
$4.44M 1.12%
26,140
+517
+2% +$85.7K
CDW icon
37
CDW
CDW
$18.9B
$4.35M 1.09%
19,124
-83
-0.4% -$17.6K
ZBRA icon
38
Zebra Technologies
ZBRA
$14B
$4.11M 1.03%
15,024
-11,881
-44% -$2.71M
UNP icon
39
Union Pacific
UNP
$174B
$4.04M 1.02%
16,458
-504
-3% -$111K
CME icon
40
CME Group
CME
$96.3B
$3.92M 0.99%
18,630
+462
+3% +$98.6K
SONY icon
41
Sony
SONY
$137B
$3.45M 0.87%
182,025
-21,780
-11% -$378K
EXPE icon
42
Expedia Group
EXPE
$35.4B
$3.42M 0.86%
22,523
+601
+3% +$73.6K
WMT icon
43
Walmart Inc
WMT
$885B
$3.15M 0.79%
59,850
V icon
44
Visa
V
$684B
$2.97M 0.75%
11,418
+295
+3% +$72.7K
NVS icon
45
Novartis
NVS
$297B
$2.57M 0.65%
25,456
+15,166
+147% +$1.46M
PFE icon
46
Pfizer
PFE
$143B
$2.03M 0.51%
70,524
+1,759
+3% +$53.2K
ABBV icon
47
AbbVie
ABBV
$443B
$1.9M 0.48%
12,242
SNY icon
48
Sanofi
SNY
$103B
$1.63M 0.41%
32,829
-9,834
-23% -$481K
ABT icon
49
Abbott
ABT
$183B
$1.34M 0.34%
12,200
UL icon
50
Unilever
UL
$137B
$962K 0.24%
17,644
-2,925
-14% -$158K

Similar funds

Foyston, Gordon, & Payne's Q4 2023 Portfolio in Review

As of Q4 2023, Foyston, Gordon, & Payne held 60 positions worth $398M, up 8.5% from $367M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q4 2023 filing shows 3 new, 16 increased, 27 reduced and 2 closed positions. Its largest new stake was Broadcom: 72,040 shares worth $8.04M. The largest sale was VMware, Inc, an estimated $7.24M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Foyston, Gordon, & Payne's largest Q4 2023 buy was Broadcom: 72,040 shares worth $8.04M.
  • Foyston, Gordon, & Payne added most to Ulta Beauty in Q4 2023, an estimated $2.81M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2023 reduction was Fiserv Inc, cutting an estimated $3.18M.
  • Foyston, Gordon, & Payne fully exited VMware, Inc in Q4 2023, selling an estimated $7.24M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $398M portfolio in Q4 2023.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 2 in Q4 2023.
  • Foyston, Gordon, & Payne's portfolio value rose 8.5% quarter-over-quarter to $398M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2023, filed 7 Feb 2024.